Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Yarning places
    Yarning places
  • Programs
    Programs
  • Organisations
    Organisations
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Jobs
    Jobs
Australian Indigenous HealthBulletin
 
  • Home
    • » Key resources and services
      • » Programs and projects
        • » Randomised controlled trial of azithromycin to reduce the morbidity of severe bronchiolitis in young Indigenous children

Randomised controlled trial of azithromycin to reduce the morbidity of severe bronchiolitis in young Indigenous children

 

Overview

This research will investigate bronchiolitis in young Indigenous children and the clinical effectiveness of the drug azithromycin compared with a placebo in treating the illness. In addition to this primary investigation the research will also look at other issues relating to acute lower respiratory tract infections in Indigenous children, specifically:

This research will draw participants from the Royal Darwin Hospital and the Townsville Hospital. 

*Macrolide is one in a class of antibiotics that inhibits the growth of bacteria and is often prescribed to treat common bacterial infections.

Australian Indigenous HealthInfoNet abstract

Contacts

Menzies School of Health Research
Email: gabrielle.mccallum@menzies.edu.au

Related publications

McCallum GB, Morris PS, Wilson CC, Versteegh LA, Ward LM, Chatfield MD, Chang AB (2013)

Severity scoring systems: are they internally valid, reliable and predictive of oxygen use in children with acute bronchiolitis?.

Pediatric Pulmonology; 48(8): 797–803

Links

 
Last updated: 20 March 2014
 
Return to top